Clinical Trial Update: Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients

View source ↗

Summary

ClinicalTrials.gov indicates a completed study evaluating abemaciclib in combination with endocrine therapy as first-line treatment for metastatic breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Technical University of Munich | Conditions: Breast Cancer/ Metastatic Breast Cancer | Status: COMPLETED